1. Home
  2. RGR vs VALN Comparison

RGR vs VALN Comparison

Compare RGR & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGR
  • VALN
  • Stock Information
  • Founded
  • RGR 1949
  • VALN 2012
  • Country
  • RGR United States
  • VALN France
  • Employees
  • RGR N/A
  • VALN N/A
  • Industry
  • RGR Ordnance And Accessories
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • RGR Industrials
  • VALN Health Care
  • Exchange
  • RGR Nasdaq
  • VALN Nasdaq
  • Market Cap
  • RGR 616.8M
  • VALN 542.5M
  • IPO Year
  • RGR N/A
  • VALN 2021
  • Fundamental
  • Price
  • RGR $35.84
  • VALN $5.90
  • Analyst Decision
  • RGR
  • VALN Strong Buy
  • Analyst Count
  • RGR 0
  • VALN 3
  • Target Price
  • RGR N/A
  • VALN $15.33
  • AVG Volume (30 Days)
  • RGR 189.4K
  • VALN 11.9K
  • Earning Date
  • RGR 07-30-2025
  • VALN 08-12-2025
  • Dividend Yield
  • RGR 1.96%
  • VALN N/A
  • EPS Growth
  • RGR N/A
  • VALN N/A
  • EPS
  • RGR 1.83
  • VALN N/A
  • Revenue
  • RGR $534,561,000.00
  • VALN $201,099,222.00
  • Revenue This Year
  • RGR N/A
  • VALN $18.74
  • Revenue Next Year
  • RGR $1.89
  • VALN $29.26
  • P/E Ratio
  • RGR $19.56
  • VALN N/A
  • Revenue Growth
  • RGR 0.65
  • VALN 21.64
  • 52 Week Low
  • RGR $32.74
  • VALN $3.62
  • 52 Week High
  • RGR $46.40
  • VALN $8.66
  • Technical
  • Relative Strength Index (RSI)
  • RGR 43.95
  • VALN 48.62
  • Support Level
  • RGR $35.53
  • VALN $5.57
  • Resistance Level
  • RGR $36.82
  • VALN $6.08
  • Average True Range (ATR)
  • RGR 0.76
  • VALN 0.26
  • MACD
  • RGR -0.04
  • VALN 0.04
  • Stochastic Oscillator
  • RGR 17.27
  • VALN 61.12

About RGR Sturm Ruger & Company Inc.

Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: